Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Last Updated: January 31, 2023

Details for Patent: 7,361,676

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Which drugs does patent 7,361,676 protect, and when does it expire?

Patent 7,361,676 protects ULORIC and is included in one NDA.

This patent has fifteen patent family members in twelve countries.

Summary for Patent: 7,361,676
Title:Solid preparation containing single crystal form
Abstract:There are provided a solid preparation containing a single crystal of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid, an excipient and a disintegrating agent, and a method for producing the same.
Inventor(s): Iwai; Michio (Osaka, JP), Nakamura; Kazuhiro (Yamaguchi, JP), Dohi; Masahiko (Tokyo, JP), Mochizuki; Hiroko (Yamaguchi, JP), Mochizuki; Seiji (Yamaguchi, JP)
Assignee: Teijin Limited (Osaka, JP)
Application Number:10/503,391
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,361,676
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form; Use;

Drugs Protected by US Patent 7,361,676

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Takeda Pharms Usa ULORIC febuxostat TABLET;ORAL 021856-001 Feb 13, 2009 AB RX Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Takeda Pharms Usa ULORIC febuxostat TABLET;ORAL 021856-002 Feb 13, 2009 AB RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,361,676

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2002-090889Mar 28, 2002
PCT Information
PCT FiledMarch 28, 2003PCT Application Number:PCT/JP03/03962
PCT Publication Date:October 09, 2003PCT Publication Number: WO03/082279

International Family Members for US Patent 7,361,676

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2003220909 See Plans and Pricing
Canada 2474674 See Plans and Pricing
China 101836978 See Plans and Pricing
China 1642546 See Plans and Pricing
Cyprus 1115490 See Plans and Pricing
Denmark 1488790 See Plans and Pricing
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.